View of Development of a Clinical Trial Protocol for the Use of a Dual GIP/GLP-1 Receptor Agonist in Patients with Heart Failure with Preserved Ejection Fraction

Return to Article Details Development of a Clinical Trial Protocol for the Use of a Dual GIP/GLP-1 Receptor Agonist in Patients with Heart Failure with Preserved Ejection Fraction Download Download PDF